Analystreport

Adaptimmune Therapeutics PLC - (NASDAQ: ADAP) had its price target raised by analysts at Mizuho from $3.00 to $9.00. They now have a "neutral" rating on the stock.

Adaptimmune Therapeutics plc - American Depositary Shares  (ADAP) 
Last adaptimmune therapeutics plc - american depositary shares earnings: 5/9 07:30 am Check Earnings Report